Want to join the conversation?
For 1Q16, $LRCX expects shipments to be $1.43Bil and revenue to be $1.30Bil, while net income per diluted share is expected to be $0.77 for the 1Q16, where it includes certain amortization-related costs and associated tax benefit for non-GAAP items of $50MM. The company also expects 1Q16 GM to be 42.4%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?